Furthermore, the authors showed that reconstituted immune cells were infiltrating transplanted tumors, and were able to delay tumor growth in a CD8+ T cell‐dependent manner when treated with a programmed death 1 (PD1) inhibitor (Wang et al., 2018). The gene discussed is CD8A; the disease is neoplasm.